Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Journal of Virology|February 13, 2023
Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA VaccinationFatima Amanat, Jordan Clark, Juan Manuel Carreño, et al.
Frontiers in Immunology|December 6, 2021
Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley RatsJohnstone Tcheou, Ariel Raskin, Gagandeep Singh, et al.
Scientific Reports|November 25, 2025
Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1Jéromine Klingler, Priyanka Gadam Rao, Juan C Bandres, et al.
Ebiomedicine|November 24, 2020
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidateWeina Sun, Sarah R Leist, Stephen McCroskery, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidateWeina Sun, Sarah R Leist, Stephen McCroskery, et al.
The Journal of Clinical Investigation|September 7, 2018
Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominanceSean T H Liu, Mohammad Amin Behzadi, Weina Sun, et al.
Molecular Pharmaceutics|June 4, 2020
Combined Intranasal Nanoemulsion and RIG-I Activating RNA Adjuvants Enhance Mucosal, Humoral, and Cellular Immunity to Influenza VirusPamela T Wong, Peter H Goff, Rachel J Sun, et al.
Vaccines|February 26, 2026
AddaVax, AddaS03, and Alum Effectively Enhance Cross-Reactive and Cross-Neutralizing Antibody Responses Against SARS-CoV-2 Induced by the Inactivated NDV-HXP-S Vaccine in MiceJosé Luis Martínez-Guevara, Tsoi Ying Lai, Mitali Mishra, et al.
Mbio|June 15, 2021
An Egg-Derived Sulfated <i>N</i>-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus VaccinesJenna J Guthmiller, Henry A Utset, Carole Henry, et al.
Vaccine|December 12, 2024
A single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challengeStefan Slamanig, Nicholas Lemus, Tsoi Ying Lai, et al.
Pageof 8